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Adjusting the thickness and internodal length of the myelin sheath is a mechanism for tuning the conduction velocity of axons
to match computational needs. Interactions between oligodendrocyte precursor cells (OPCs) and developing axons regulate
the formation of myelin around axons. We now show, using organotypic cerebral cortex slices from mice expressing eGFP in
Sox10-positive oligodendrocytes, that endogenously released GABA, acting on GABAA receptors, greatly reduces the number
of oligodendrocyte lineage cells. The decrease in oligodendrocyte number correlates with a reduction in the amount of myeli-
nation but also an increase in internode length, a parameter previously thought to be set by the axon diameter or to be a
property intrinsic to oligodendrocytes. Importantly, while TTX block of neuronal activity had no effect on oligodendrocyte lin-
eage cell number when applied alone, it was able to completely abolish the effect of blocking GABAA receptors, suggesting
that control of myelination by endogenous GABA may require a permissive factor to be released from axons. In contrast,
block of AMPA/KA receptors had no effect on oligodendrocyte lineage cell number or myelination. These results imply that,
during development, GABA can act as a local environmental cue to control myelination and thus influence the conduction
velocity of action potentials within the CNS.
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Introduction
By speeding action potential conduction, myelination ofCNS axons by oligodendrocytes increases the brain’s cog-
nitive abilities. During development or learning, an adjust-
ment of myelin thickness or internode length may be used to
tune the conduction speed of myelinated axons (Fields, 2008;
Ullen, 2009). This can promote synchronous neuronal firing
(Lang and Rosenbluth, 2003; Sugihara et al., 1993), make
impulse propagation time less dependent on the spatial trajec-
tory of the axon transmitting information between areas
(Salami et al., 2003), or adjust propagation delays to mediate
sound localization (Ford et al., 2015; Jeffress, 1948; McAl-
pine and Grothe, 2003; Seidl et al., 2010). Magnetic reso-
nance imaging (MRI) reveals changes to white matter
microstructure—perhaps reflecting alterations of myelina-
tion—when human subjects learn a skilled motor task such as
playing the piano (Bengtsson et al., 2005) or juggling (Scholz
et al., 2009). Analogous MRI changes, accompanied by ele-
vated myelin basic protein (MBP) expression, are observed in
rats trained to grasp food pellets (Sampaio-Baptista et al.,
2013), and new myelin production is necessary for mice to
become skilled wheel runners (McKenzie et al., 2014).
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Together, these studies suggest that adaptive myelination is a
normal and essential aspect of neural plasticity.
The proliferation of oligodendrocyte precursor cells
(OPCs) must be controlled in order to generate the correct
number of oligodendrocytes to ensheath the length of axons
requiring to be myelinated. OPC proliferation and myelina-
tion are coordinated by communication between the axons to
be myelinated and the developing oligodendrocyte lineage
cells. This has long been known to involve growth factors,
but OPCs also receive excitatory and inhibitory synaptic
input mediated by glutamate and GABA (Bergles et al.,
2000; Ge et al., 2009; Lin and Bergles, 2004; Karadottir
et al., 2005, 2008; Kukley et al., 2007, 2008; Ziskin et al.,
2007; Zonouzi et al., 2015), suggesting that these neurotrans-
mitters may also control oligodendrocyte development and
myelination. Glutamate has been suggested to block the pro-
liferation and lineage progression of OPCs (Gallo et al.,
1996; Yuan et al., 1998), but also promotes myelin formation
(Lundgaard et al., 2013; Wake et al., 2011). Endogenous
GABA has been reported to have no effect on OPC develop-
ment (Gallo et al., 1996; Yuan et al., 1998), but may stimu-
late OPC migration (Tong et al., 2009) and, by inhibiting
neuronal activity, might be expected to decrease myelination
(Malone et al., 2013; Sampaio-Baptista et al., 2013). Howev-
er, during hypoxia, a decrease of GABAA receptor mediated
signaling to OPCs increases their proliferation whilst delaying
myelination (Zonouzi et al., 2015).
Here we demonstrate a strong effect of endogenous
GABA release on oligodendrocyte development in cerebral
cortical slices. By acting on GABAA receptors, GABA almost
halves the number of OPCs and mature oligodendrocytes
produced. Consequently, myelin coverage of axons is
decreased. Furthermore, the change in the number of OPCs
produced is shown to regulate the myelin sheath internode
length, which has previously been postulated to be set solely
by the axon diameter (Rushton, 1951) or to be an intrinsic
property of the oligodendrocytes carrying out the myelination
(Bechler et al., 2015). Thus, GABA release from inhibitory
interneurons can tune the conduction speed of CNS axons.
Materials and Methods
Organotypic Cortical Slices and Myelination Assay
Sox10-lox-GFP-STOP-lox-DTA (called Sox10-GFP below) mice
express GFP in oligodendrocyte lineage cells (Kessaris et al., 2006),
which allowed us to develop an assay for myelination in organotypic
brain slices in which oligodendrocyte lineage cells fluoresce green,
and neuronal axons and myelin are identified and quantified with
immunofluorescence (Fig. 1). Using this model we could assess
whether changes in myelination reflected changes in the number of
oligodendrocyte lineage cells, axonal density or the myelinating activ-
ity per oligodendrocyte lineage cell.
Coronal cortical slices (350 mm) from 8 day old transgenic
mice were cut, and cultured (De Simoni and Yu, 2006; Rinholm
et al., 2011) in medium containing 50% Minimal Essential Medium
(MEM), 23% Earl’s Balanced Salt Solution (EBSS), 25% horse
serum, penicillin (25 units/mL) and streptomycin (25 mg/mL), all
from Gibco-Invitrogen, and 1.125% nystatin (12.5 units/mL),
36 mM glucose and 5 mM Tris base from Sigma-Aldrich, at 378C
in a humidified atmosphere with 5% CO2. The extracellular concen-
trations of major ions were (mM) NaCl 115, NaHCO3 34,
NaHP04 1, KCl 5.2, CaCl2 1.9, MgCl2 1.1. The feeding medium
was changed every 3 or 4 days. After 2 weeks the slices were fixed
and immunolabeled with markers for myelin (MBP primary, and
AlexaFluor 555 secondary antibodies) and axons (neurofilament
(NF) 200 primary and Cy5.5 secondary antibodies: this emission is
recolored blue in the figures). Images (confocal Z stacks) were taken
of myelination within the gray matter of layers I–VI.
Myelination develops over about 2 weeks in these cultured sli-
ces (Fig. 1A,E). Initially many oligodendrocyte lineage cells are visi-
ble but, as neuronal processes develop, these become fewer in
number as a result of cell death, and differentiate so that MBP
appears. Larger magnification pictures of the cultures and electron
microscope images (Fig. 1B–D) reveal that the great majority of the
MBP is in compact myelin in close apposition to neurofilament-
labeled processes (only 11% of MBP labeled processes were not
clearly wrapping neurofilament labeled axons, and those might be
processes connecting internodes to the oligodendrocyte somata, or
wrapping axons in which the neurofilament labeling was too weak to
see). Thus, very few oligodendrocytes express MBP before they mye-
linate, and labeling is concentrated in compact myelin around axons.
By counting the number of GFP expressing cells, and using
the total fluorescence of secondary antibodies to the NF antibody
and to the MBP antibody as measures of the amount of neuronal
processes and of myelin present (Rinholm et al., 2011), the progress
of myelination in the cultures can be assessed as in Fig. 1E. During
the first few days in culture the number of oligodendrocyte lineage
cells increases as OPCs proliferate, which is followed by a decrease
to below the initial number as cells die. After about a week the
number of neuronal processes reaches a plateau, while myelination
continues for at least another week. To quantify the amount of mye-
lin per neuronal process, we calculated the ratio of the MBP fluores-
cence to NF fluorescence. At high magnification, in the centre of
the cortex, gaps in the myelin corresponding to ankyrin G-
expressing nodes of Ranvier can be seen (Figs. 1B and 5A), allowing
quantification of the number of nodes present and of internode
length (Fig. 5F).
Myelination was quantified (with Metamorph or Image J)
either by measuring the peak intensity of MBP labeling divided by
that of the axon labeling (NF200) in the confocal stack image with
the largest intensity in each stack, to obtain a measure of myelina-
tion per axon (Rinholm et al., 2011), and then averaging over 2-6
stacks from each slice, or by counting the fraction of axons myelinat-
ed in four contiguous regions (Fig. 4I, 30 mm by 25 mm), the overall
position of which was chosen randomly. The amount of myelin per
length of axon was measured by placing a 3 mm by 3 mm square
over the first (from the top left corner) myelinated axon found cross-
ing the top edge of each of the regions in Fig. 4I and integrating the
MBP intensity over this 3 lm square area. The internode length of
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the myelin sheath was measured between two nodes of Ranvier, one
at least of which was within a 92 lm by 160 lm region initially
imaged, and the internode was followed to its end even if that was
outside the initially imaged region (Fig. 5F). These measurements of
sheath length are approximately 1 lm shorter than the length that
would be measured from the centre of one node to the centre of the
next. Measurements of the fraction of axons myelinated, the amount
of myelin per length of axon, the number of nodes of Ranvier per
field of view, the length of Ranvier nodes and the length of interno-
des were collected with the experimenter being blind to the
experimental condition. When measuring internode length, 80% of
internodes remained within one 1.38 lm thick confocal image
plane, while 20% extended across 2 adjacent planes in depth. The
maximum error this could induce in the derived value for the inter-
node length was 0.14%.
Immunocytochemistry
To label organotypic slice cultures, slices were fixed in 4% parafor-
maldehyde in PBS for 1 h, then rinsed three times (for 10 min) in
PBS followed by preincubation in 0.5% Triton and 10% goat serum
FIGURE 1: Development of myelination in cultured cortical slices. A: Cortical slices from mice with oligodendrocyte lineage cells expressing
GFP (under control of the Sox10 promoter, green) after different numbers of days in vitro (DIV). Blue is antibody to neurofilament 200
(NF200) and shows axons; red is antibody to myelin basic protein (MBP). Slice orientation is approximately with the pial surface at the top
and the corpus callosal surface at the bottom. Band of heavy myelination at DIV14 is in layers IV-V (the Baillarger lines). B: Higher magnifica-
tion view of cultures showing neurofilament in axons, some of which are wrapped with MBP containing myelin (green GFP channel not
shown). C: A myelinated axon imaged in cross section. D: EM picture of myelin sheath (large bracket in inset) in cultured slice. The inter-
dense line distance (small bracket) was 12.5560.19 nm and the g ratio was 0.8160.01 in 48 sheaths. E: Mean values of numbers of GFP
expressing cells/mm2 (green, right axis) and mean fluorescence (left axis) of NF200 (blue) and MBP (red) averaged over 920 lm by 920 lm
images (8–15 images at different ages, using 3 animals in each of 2 experiments).
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in PBS for 6–8 h at room temperature. The slices were then incu-
bated with primary antibodies for 36 h at room temperature with
slight agitation, rinsed in PBS three times (for 10 min), and then
incubated with secondary antibodies for 3 h before being rinsed
again in PBS 3 times (for 10 min). Slices were finally mounted on a
microscope slide with Citifluor (glycerol/PBS, Citifluor), covered
with a 0.17 mm thick glass cover slip, and sealed with nail varnish
(Boots, UK). The primary antibodies used were myelin basic protein
(MBP, mouse, IgG, 1:100, Millipore, or rat, IgG 1:200, Millipore),
200kD neurofilament heavy (NF200, chicken, IgY, 1:10000 Abcam),
ankyrin G (AnkG, rabbit, IgG, 1:400, Santa Cruz), APC (mouse,
IgM, 1:50, Calbiochem), cleaved caspase 3 (rabbit, 1:200, Cell Sig-
naling), and NG2 (rabbit, 1:400, Millipore). The secondary anti-
bodies were AlexaFluor antibodies raised in goat (anti-mouse 350,
anti-rat 555, anti-rat 350, anti-rabbit 568 and 633, anti-chicken
488) or donkey (anti-rabbit 647), all from Molecular Probes, or
CY5.5 goat anti-chicken IgY from Abcam or Jackson Labs.
EdU Labeling and Detection
5-ethynyl-2’-deoxyuridine (EdU) (Invitrogen) is a thymidine ana-
logue that is incorporated into the DNA of cells as they undergo
DNA replication (Chehrehasa et al., 2009). EdU was added to the
organotypic slice medium at a concentration of 10 mM, on DIV4
for 48 h, to quantify the percentage of cells that divide between
Days 4 and 6 in vitro. EdU developing was performed immediately
following immunocytochemistry, with the Click-iT EdU Alexa
Fluor-594 Imaging Kit (Invitrogen). Slices were immersed in Click-
iT developing cocktail and incubated for 45 min at 21C in the
dark, according to the manufacturer’s instructions. Slices were
washed three times in PBS and post-stained with DAPI (300 nM,
Molecular Probes) to visualize cell nuclei.
Electron Microscopy
At DIV14 organotypic slices were immersion fixed in 2% parafor-
maldehyde and 2% glutaraldehyde in 0.1 M cacodylate buffer over-
night. All slices were then post-fixed in 1% OsO4/0.1 M cacodylate
buffer (pH 7.3) at 38C for 2 h before washing in 0.1 M cacodylate
buffer (pH 7.3). The slices were dehydrated in a graded ethanol-
water series at 38C and infiltrated with Agar 100 resin mix. The slice
was then cut perpendicularly to the plane of the slice (in the cortical
region where myelination within the organotypic slice is most
dense), blocked out, and hardened. Ultra-thin sections were taken
on a Reichert Ultracut S microtome. Sections were collected and
stained with lead citrate. The sections were imaged using a Joel
1010 transition electron microscope and a Gatan Orius camera.
Cortical OPC Cultures
These were as described by Lundgaard et al. (2013). Briefly, purified
oligodendrocyte precursors were obtained using the shake off meth-
od of McCarthy and de Vellis (1980) applied to mixed glial cultures
that had been cultured for 10 days. They were resuspended in
DMEM media with modified SATO serum-free supplement (100
mg/mL BSA, 60 ng/mL progesterone, 16.1 mg/mL putrescine, 5 ng/
mL sodium selenite, 5 mg/mL insulin, 5 mg/mL N-acetyl-L-cysteine,
50 mg/mL holo-transferrin and 1% Pen/Strep) and growth factors
(PDGF-aa at 10 ng/mL and FGF-b at 10 ng/mL from Peprotech;
UK). OPCs were seeded at a density of 22 3 103 cells/cm2 onto
PDL coated glass coverslips yielding a purity of 866 2% (n5 18)
NG21 cells after 3 days of proliferation (following the 10 days in
culture with other glia).
Electrophysiology
For studying the electrophysiology of OPCs, they were identified
from their dye-fill morphology and I-V relations, and were whole-
cell clamped with pipettes of series resistance 5–20 MX. Electrode
junction potentials were compensated. For experiments assessing
OPC electrophysiology in organotypic slices, they were superfused at
336 18C with bicarbonate-buffered solution containing (mM) 126
NaCl, 24 NaHCO3, 1 NaH2PO4, 2.5 KCl, 1 MgCl2, 2 CaCl2, bub-
bled with 95% O2/5% CO2, pH 7.4. The OPCs were voltage
clamped at 264 mV and ECl was set to 24 mV with KCl-based
solution containing (mM) 130 KCl, 4 NaCl, 1 CaCl2, 10 HEPES,
10 EGTA, 4 MgATP, 0.5 Na2GTP, 0.05 AlexaFluor594 (pH 7.15).
For experiments assessing OPC electrophysiology in culture, the cells
were clamped at 244 mV and superfused at 228C with HEPES-
buffered solution containing (mM): 144 NaCl, 2.5 KCl, 10 HEPES,
1 NaH2PO4,2.5 CaCl2, 10 glucose (pH 7.4). ECl was set to 287
mV by using a K-gluconate based internal solution containing
(mM): 130 K-gluconate, 4 NaCl, 0.5 CaCl2, 10 HEPES, 10
BAPTA, 4 MgATP, 0.5 Na2GTP, 2 K-Lucifer yellow (pH 7.3).
Statistics
Data are shown as mean6 s.e.m. Unless stated otherwise, Student’s
2-tailed t-tests were used. For multiple comparisons, P values were
corrected using a procedure equivalent to the Holm-Bonferroni
method (for N comparisons in an experiment, the most significant P
value is multiplied by N, the 2nd most significant by N-1, the 3rd
most significant by N-2, etc.; corrected P values are considered sig-
nificant if they are less than 0.05). Analysis of variance showed that
most variability in the data was between different slices rather than
between experiments done on different days, so when pooling data
between different experiments we used the number of slices as the
number of observations for statistical calculations. Numbers on fig-
ure bars show number of slices, except where stated otherwise.
Results
GABA, But Not Glutamate, Regulates the Number
of Oligodendrocyte Lineage Cells
GABA evokes a current in OPCs (Lin and Bergles, 2004),
and will also alter neuronal firing which can influence OPC
proliferation and myelination (Gibson et al., 2014). To inves-
tigate the role of GABA in regulating oligodendrocyte devel-
opment we used organotypic brain slices made from the
frontal cortex of mice that express GFP in oligodendrocyte
lineage cells (see Materials and Methods). Because the slices
are able to retain the cyto-architecture found in the cortex for
many weeks, they are a good model to study neuron-glial
communication while allowing pharmacological manipula-
tion. Fixing slices after different durations in culture, and
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labeling for neurofilament 200 (NF) and myelin basic protein
(MBP), allowed us to image neuronal processes, oligodendro-
cyte lineage cells and myelin, and to monitor the develop-
ment of compact myelin (Fig. 1).
To test the effect of endogenously released glutamate
and GABA on the number of oligodendrocyte lineage cells
generated, we included the NMDA receptor blocker MK-801
(50 lM), the AMPA/KA receptor blocker NBQX (25 lM)
or the GABAA receptor blocker GABAzine (50 lM; bicucul-
line was not used because it also blocks K1 channels: Seutin
and Johnson, 1999) in the culture medium from days 3 to
14 in vitro. Blocking NMDA receptors led to a 406 12%
decrease (P5 0.02) of the amount of neurofilament labeling
in the cultures, probably because neurons need a basal level
of NMDA receptor activation to survive (Hardingham and
Bading, 2003), which precluded a meaningful analysis of
whether NMDA receptors regulate myelination. Deleterious
effects on neurons were not observed when blocking AMPA/
KA or GABAA receptors. NBQX, which blocks excitatory
synaptic transmission from axons to OPCs (Kukley et al.,
2007; Ziskin et al., 2007), had no effect on the number of
oligodendrocyte lineage cells present at DIV14 (Fig. 2A,B),
nor on the amount of labeling for neurofilament (reduced by
36 11%, P5 0.81) or MBP (increased by 46 6%,
P5 0.75). In contrast GABAzine, which blocks inhibitory
synaptic transmission, dramatically increased the number of
oligodendrocyte lineage cells (Fig. 2A,B); the increase over 7
independent sets of cultures (each from 2-3 animals) was
1.766 0.08 fold (Fig. 2B), implying that endogenous GABA
release normally decreases the number of oligodendrocyte lin-
eage cells by a factor of 1/1.76 or 43%.
The larger population of oligodendrocyte lineage cells
observed in the presence of GABAzine included more mature
oligodendrocytes. Using the combination of Sox10-GFP
expression and adenomatous polyposis coli (APC) antibody
labeling to define mature oligodendrocytes (Bhat et al., 1996)
we found that, by 2 weeks in culture, GABAzine produced a
large fractional increase in the number of mature (APC-
expressing) oligodendrocytes (increased by 73%) as well as in
the number of APC-negative GFP-positive OPCs (increased
by 48%, Fig. 2D–G). Thus, endogenous GABA, acting via
GABAA receptors, greatly decreases the number of both
OPCs and mature oligodendrocytes. Increasing GABAA
receptor activation, by applying muscimol (10 lM) (Yuan
et al., 1998), decreased the number of oligodendrocyte line-
age cells present at DIV14 by 236 6% (Fig. 2B). Thus,
increases and decreases of GABAA receptor activation bidirec-
tionally alter the number of oligodendrocyte lineage cells.
The increase of the number of oligodendrocyte lineage
cells produced by GABAzine did not appear to depend on
NKCC1 transporters accumulating Cl- in the cell to shift
positive the reversal potential for GABAA receptors (so that
GABA depolarizes OPCs: Lin and Bergles, 2004; Tyzio et al.,
2011). Blocking NKCC1 with bumetanide (100 lM, from 3
to 14 days in vitro) had no effect on the change of number
of oligodendrocyte lineage cells produced by GABAzine or
muscimol (Fig. 2B). Blocking GABAB receptors with 50 lM
CGP35348 or activating them with 10 lM baclofen also had
no effect on the number of oligodendrocyte lineage cells pre-
sent (Fig. 2B), unlike a previous report for pure OPC cultures
(Luyt et al., 2007).
GABA Regulates the Proliferation and Death of
Oligodendrocyte Lineage Cells
GABAzine could increase the number of oligodendrocyte lin-
eage cells either by blocking a GABA-mediated suppression of
OPC proliferation, or by blocking GABA-evoked cell death.
To investigate this we applied GABAzine from 3-6 days in
vitro, i.e. the period in Fig. 1E when OPC proliferation dom-
inates. At day 6, NG2-expressing OPCs were the majority of
the oligodendrocyte lineage cells (68.56 2.8% in control sli-
ces and 74.66 2.4% in GABAzine treated slices, not signifi-
cantly different, P5 0.11). By DIV6, GABAzine had evoked
an increase in the number of oligodendrocyte lineage cells
(Fig. 2C) similar to that seen at DIV 14 (Fig. 2B), and apply-
ing GABAzine after P6 had much smaller effects (data not
shown) demonstrating that the effects of GABAA signaling
are exerted mainly at the OPC/early oligodendrocyte stage of
development.
Using EdU, we found that GABAzine increased the
fraction of OPCs that were dividing between days 4 and 6 in
vitro (Fig. 3A–C). In addition, labeling for apoptotic cell
death at day 6 in vitro with antibody to cleaved caspase-3,
showed that GABAzine reduced the proportion of SOX10-
GFP cells undergoing apoptosis (Fig. 3D–F). Thus, endoge-
nous GABA release normally suppresses OPC proliferation
and increases cell death.
We investigated whether these effects of GABA were
directly on OPCs, or mediated by changes of neuronal firing,
or involved effects both on OPCs and on neurons. A direct
suppressive effect of GABA on the proliferation of neural
stem cells, mediated by a PI3K-related kinase (PIKK) and his-
tone H2AX, has been reported (Fernando et al., 2011). If
GABA acts in the same way on OPCs then blocking the
action of PIKK should mimic the effect of GABAzine in our
experiments. However, we found that block of PIKK (using
ATM kinase inhibitor, 10 lM) had no effect on the number
of oligodendrocyte lineage cells (decreased by 36 3% in 3
experiments using a total of 22 slices for each condition, not
significant: P5 0.43).
Blocking neuronal firing by applying 1 lM TTX from
Days 3 to 6 in vitro also had no effect on the number of
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FIGURE 2: Blocking GABAARs increases the number of oligodendrocyte lineage cells. A: Cortical slices at DIV14 after culture in control
conditions, or with GABAA or AMPA/KA receptors blocked with GABAzine or NBQX respectively. B: Number of Sox10-GFP-expressing
cells, in control conditions and with the indicated drugs present from DIV3-14 (Gz, GABAzine; Musc, muscimol; CGP, CGP35348; Bac,
baclofen). P values are Holm-Bonferroni corrected for 5 comparisons for Gz, Musc, Bumetanide, CGP, Bac, and for 2 comparisons when
comparing Bumetanide1Gz or Bumetanide1Musc with Bumetanide (numbers on bars are total numbers of slices from 12 experiments
using two or three animals each). C: Effect of GABAzine from DIV3-6 on number of GFP-expressing cells at DIV6 (numbers on bars are
total numbers of slices from 7 experiments using two or three animals each). D: Labeling of oligodendrocyte lineage cells (expressing
GFP, green) for the mature oligodendrocyte marker APC (white) and for MBP (red). Top arrowed GFP-expressing cell expresses APC, as
well as MBP in its myelinating processes (top thin arrow indicates a primary process linking the arrowed soma to a MBP expressing pro-
cess), unlike the bottom cell. E: Number of cells expressing GFP and APC in the presence of GABAzine, normalized to the number in
control conditions (numbers on bars are total number of slices from 3 experiments using 3 animals each). F: Labeling of oligodendrocyte
lineage cells (expressing GFP, green) for APC (white) and for the OPC marker NG2 (red). Unlike the left cell which expresses APC, the
right arrowed cell lacks APC and expresses NG2. G: Number of cells expressing GFP but not APC in the presence of GABAzine, normal-
ised to the number in control conditions (numbers on bars are as in E).
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OPCs produced (decreased by 2.9%, not significant,
P5 0.7), but blocked the increase in OPC number produced
by GABAzine (Fig. 3G, increased by 8.4%, not significant,
P5 0.61). If GABA affects proliferation and cell death solely
by acting directly on OPCs, this block could be explained by
TTX suppressing action potential evoked release of GABA
onto OPCs, or blocking voltage-gated Na1 channels in
OPCs that are activated by the depolarization (Lin and Ber-
gles, 2004) that GABA produces. However, in both these sce-
narios, TTX alone should produce the same increase in
proliferation as GABAzine, but it did not (Fig. 3G). An alter-
native hypothesis is that the increase in OPC number evoked
by GABAzine, and its block by TTX, may be due to GABA-
zine increasing neuronal action potential firing, leading to the
release from neurons of a factor promoting OPC proliferation
and decreasing OPC death. However, although the GABAA
agonist muscimol (which should reduce neuronal firing)
decreased the number of oligodendrocyte lineage cells (Fig.
2B), TTX (which should abolish firing completely) had no
effect (Fig. 3G). These results might, however, be explained if
FIGURE 3: Endogenous GABA release decreases proliferation and increases death of oligodendrocyte lineage cells. A,B: Example of
EDU labeling (red) in NG2 expressing cells (green) without (A) and with (B) GABAzine. C: Quantification of fraction of OPCs dividing
between DIV4-6 (numbers on bars are total number of slices from 2 experiments, each using 3 animals). D-E: Example of cleaved cas-
pase 3 labeling (red) in SOX10-GFP expressing cells (green) without (D) and with (E) GABAzine. F: Quantification of fraction of oligoden-
drocyte lineage cells labeling for cleaved caspase 3 at DIV6 (numbers on bars are total number of slices from 2 experiments each using
3 animals). G: TTX has no effect alone on the number of oligodendrocyte lineage cells, but blocks its increase by GABAzine (numbers on
bars are number of slices from 3 experiments each using 3 animals). H: NBQX does not affect the number of oligodendrocyte lineage
cells nor its increase by GABAzine (numbers on bars are total number of slices from 2 experiments each using 2 animals).
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there are two effects regulating OPC proliferation: a direct
effect of GABA on OPCs which suppresses proliferation
(Zonouzi et al., 2015), and release of a factor by active neu-
rons that induces the expression of GABAA receptors or sig-
naling molecules downstream from them, that enables the
number of oligodendrocyte lineage cells to be regulated by
GABA (see Discussion).
In order to determine whether neuronal activity was
needed to maintain GABAA receptor expression in OPCs (cf.
Arellano et al. (2016) who found that the presence of neurons
is needed, but that activity is not), we applied TTX to the
organotypic slices. We measured GABA-evoked currents at
264 mV (with ECl5-4 mV) in patch-clamped Sox10-GFP-
expressing OPCs after incubation in TTX from DIV3 to
DIV6, and found that the currents were not significantly
reduced (19% decrease, P5 0.53, n5 9 with and n5 9 with-
out TTX), in agreement with the lack of dependence of
expression on neuronal spiking seen by Arellano et al. (2016).
We attempted to determine whether GABA has direct
effects on OPC proliferation by making cortical OPC cul-
tures and activating GABAA receptors with muscimol. In
accordance with a recent publication from the Matute labora-
tory (Arellano et al., 2016), GABAA receptor mRNA expres-
sion was downregulated (by 83% and 78% respectively) for
the GABAA receptor a1 and b2 subunits in pure OPC cul-
tures without the presence of neurons or neuronal-
conditioned media (after 10 days in mixed glial culture: see
Methods). However, a GABAA receptor mediated current was
still observed in these cells (at DIV3 in pure OPC cultures
after 10 days in mixed glial culture: see Methods). An out-
ward current of 386 8 pA was evoked by 100 lM GABA at
244 mV with ECl set to 287 mV, implying that GABAA
receptors were still functional in the cells. We found that acti-
vating GABAA receptors with muscimol (10 lM), blocking
them with GABAzine (50 lM) or applying TTX (1 lM),
from DIV1 to DIV3 in pure OPC culture, had no effect on
the number of proliferating cells, generating a 6.5% increase
(P5 0.41), a 7.6% increase (P5 0.46), and a 3.5% decrease
(P5 0.98), respectively.
Activation of voltage-gated Na1 channels in OPCs by
the depolarization produced by glutamatergic excitatory syn-
aptic input to OPCs does not contribute to the GABAzine-
evoked increase in OPC number, because having NBQX pre-
sent with the GABAzine did not prevent the increase in cell
number produced by GABAzine (Fig. 3H).
Endogenous GABA Release Decreases Myelination
In contrast to the effect of GABAzine and muscimol on oli-
godendrocyte lineage cell number, neurofilament labeling was
unaffected by these drugs, implying little effect on the growth
of neuronal processes, while total MBP fluorescence was
increased by 426 19% by GABAzine and decreased by
336 7% by muscimol (Fig. 4A–F). As an index of myelina-
tion per neuronal process, we normalized the summed fluo-
rescence of the MBP present to the summed fluorescence of
the neurofilament present. GABAzine increased this index by
266 10%, while muscimol decreased it by 376 6% (Fig.
4G,H). The GABAzine-evoked myelination increase was, in
part, the result of GABAzine increasing by 256 6% the frac-
tion of axons myelinated, without significantly changing the
number of axons present (Fig. 4I-K). This implies that
endogenous GABA release normally decreases the fraction of
axons myelinated by a factor of 1/1.25 or 20%.
By selecting only myelinated axons, and measuring the
MBP fluorescence per length of axon (Fig. 4L), we found
that GABAzine also increased the amount of myelin labeling
per length of axon by 286 11% (Fig. 4M), implying that
endogenous GABA release normally decreases the amount of
myelin per myelinated axon by a factor of 1/1.28 or 22%.
This might reflect an increase in myelin thickness, or in axon
diameter (measurement of which is inaccurate in our light
microscopy images), or both. Thus, endogenous GABA
release normally decreases both the fraction of axons myelin-
ated and the amount of myelin per axon.
Endogenous GABA Increases Internode Length
The myelin sheath internode length has previously been pos-
tulated to be set solely by the axon diameter (Rushton, 1951)
or to be an intrinsic property of the oligodendrocytes carrying
out the myelination (Bechler et al., 2015). However, in
GABAzine there are more OPCs competing to myelinate the
same number of axons. In addition to this being a possible
reason why more axons become myelinated, it may result in
each oligodendrocyte making shorter internodes. We identi-
fied Ranvier nodes using antibody to ankyrin G, or as gaps
in the MBP- and GFP-labeling of the myelinating processes
of oligodendrocytes (Fig. 5A). GABAzine increased, while
muscimol decreased, the number of nodes in each 146 lm
square field of view (Fig. 5B). The 47% increase in node den-
sity produced by GABAzine is larger than the 25% increase
in the number of axons myelinated (Fig. 4K), implying that
GABAzine decreases the separation of nodes along axons, i.e.
decreases the internode length. GABAzine and muscimol did
not alter the lengths of the nodes themselves (Fig. 5C–E).
The distribution of internode lengths differed significantly
between control slices and GABAzine-exposed slices (Fig. 5F–
G), corresponding to a 13% decrease of mean internode
length in GABAzine treated slices (Fig. 5H: the Gaussian fits
to the distributions in Fig. 5G predict a 21% decrease),
which implies that endogenous GABA release normally
increases the mean internode length by a factor of 1/1.13 or
12%.
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FIGURE 4: Endogenous GABA release decreases myelination. A, C, E, G: Cortical slices at DIV14 after culture in control conditions, or
with GABAzine or muscimol present from DIV3-14, showing labeling for (A) Sox10-GFP, (C) neurofilament (NF200), (E) MBP and (G) all
the labels. B, D, F: Quantification (averaged over the whole image) of the labeling in the panels to the left (panel B is similar to the 1st,
3rd, and 4th bars in Fig. 2B but using data only for the slices from which panels D, F, and H were obtained; numbers on bars are total
number of slices from 7 experiments using 2 or 3 animals each). H: Ratio of labeling for MBP to that for NF200. I: Specimen labeling
with superimposed squares for quantification of the fraction of NF200-expressing axons (blue) that are myelinated (i.e., wrapped with
MBP, red). J-K: Effect of GABAzine from DIV3-14 on the number of axons present per rectangle (J) and the percentage of axons myelin-
ated (K); numbers are total number of areas from 8 slices, in 2 experiments with 3 mice each. L: Specimen image of myelinated axon,
with 3 lm long region of interest used to quantify the amount of MBP per micron of axon. M: Effect of GABAzine on MBP fluorescence
intensity per micron of axon. Numbers on bars are total number of axons in 8 slices, from 2 experiments using 3 mice each.
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Discussion
Our data reveal that the neurotransmitter GABA exercises a
major influence on the number of oligodendrocyte lineage
cells in situ in cerebral cortical slices. Blocking the effects of
GABA on GABAA receptors nearly doubled the number of
oligodendrocyte lineage cells (Fig. 2A,B), increased myelina-
tion (Fig. 4G,H) and decreased internode length (Fig. 5G,H).
Thus, endogenous GABA release is important in determining
the development of these cells (Zonouzi et al., 2015).
In contrast, blocking endogenous glutamatergic excita-
tion had no effect on the number of oligodendrocyte lineage
cells (Fig. 2B). These observations are in contrast to those of
Yuan et al. (1998), who found that glutamate decreased the
number of oligodendrocytes in cerebellar slices, while GABA
had no effect. The reason for this difference is unclear
(although we note that LoTurco et al. (1995) found a
suppressive effect of GABA on cortical progenitor cell
proliferation, similar to what we find for oligodendrocyte lin-
eage cells). It may imply a difference between the neocortex
and the cerebellar cortex in the mechanisms regulating cell
proliferation and myelination.
The increase in the number of CC1-expressing mature
oligodendrocytes and myelination seen in the presence of
GABAzine contrasts with the inhibition of lineage progression
reported by Zonouzi et al. (2015) when the GABAA receptor
blocker bicuculline was injected in vivo. This could reflect
the fact that bicuculline salts have nonspecific actions and, in
addition to blocking GABAA receptors, also block Ca
21-acti-
vated K1 channels (Seutin and Johnson, 1999). The increase
of myelination is presumably a result of the increase in
the number of oligodendrocyte lineage cells which is pro-
duced (Fig. 3A–F) by an increase of proliferation of OPCs,
and also a decrease of cell death (which occurs both at the
OPC stage and after differentiation into pre-myelinating
FIGURE 5: Endogenous GABA release increases internode length. A: Myelinated axon node of Ranvier labeled for ankyrin G (Ank G),
myelin basic protein (MBP) and neurofilament (NF200); right panel shows merged image. B: Nodes per 146 lm square field of view at
DIV14, in control conditions, or with GABAzine or muscimol present from DIV3-14. Numbers on bars are fields of view; 6-10 fields were
taken per slice (a total of 6 slices were used from 2 mice). C-E: Node lengths (measured from all the nodes imaged for panel B) in differ-
ent conditions assessed as: (C) gap between end of internodal MBP labeling, (D) gap between internodal GFP, and (E) length of ankyrin
G labeling. Numbers on bars are total numbers of nodes counted in B. F: Example of internode length measurement. Nodes are identi-
fied as gaps in GFP and MBP labeling. G: Distribution of internode lengths, L (in 10 lm bins), at DIV14, in control conditions (in eight 92
lm x 160lm images from 4 slices taken from 2 animals), or with GABAzine present from DIV3-14 (7 images from 4 slices). Fits are
Gaussian curves, {A/[r(2p)]}exp{-(L-M)2/(2r2)}, with parameters A5991, mean length M548.9 lm, r520.3 lm in control and A51004,
M538.5 lm, r523.3 lm in GABAzine. P value showing significantly different distributions is from Kolmogorov-Smirnov test. H, Mean
internode length from (G); numbers on bars are internodes.
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oligodendrocytes: Barres et al., 1992; Trapp et al., 1997). The
increased number of OPCs available for myelination (Fig.
2B,C,G) increases the fraction of axons that become myelin-
ated (Fig. 4K) and decreases internode length, presumably
because more OPCs myelinate the same axon (Fig. 5F–H).
Thus, the number of oligodendrocyte lineage cells that are
produced and survive—and the resulting myelination—are
determined not only by a cell-intrinsic clock and/or the avail-
ability of growth factors (Raff et al., 1988; Calver et al.,
1998; van Heyningen et al., 2001), but also by locally
released GABA.
How GABAergic signaling suppresses proliferation and
increases cell death remains unclear. We have shown that it
does not depend on the reversal potential for GABA-evoked
currents being maintained positive to the resting potential by
NKCC1, since the effect of GABAzine on oligodendrocyte
lineage cell number was unaffected by blocking NKCC1 with
bumetanide (Fig. 2B), and so is unlikely to reflect GABA-
evoked depolarization initiating a Ca21 influx through
voltage-gated calcium channels (although we cannot rule out
the possibility that another mechanism keeps [Cl-]i high). In
contrast, Zonouzi et al. (2015) observed that knock-out of
NKCC1 had effects similar to the application of bicuculline.
We considered the following hypotheses for how GABAzine
might increase the number of oligodendrocyte lineage cells.
First we postulated that GABA regulates proliferation
solely by acting on oligodendrocyte lineage cells (as suggested
by Zonouzi et al., 2015). The increase of OPC number pro-
duced by GABAzine (Fig. 2B), would then imply that there is
a tonic release of endogenous GABA onto OPCs. The lack of
effect of TTX on proliferation (Fig. 3G) would imply that this
GABA release is not action potential driven. On this hypothe-
sis, therefore, the GABA would have to be released in an action
potential independent manner, perhaps from OPCs or astro-
cytes, as both synthesize GABA from putrescine using mono-
amine oxidase B (Barres et al., 1990; Yoon et al., 2014).
Inconsistent with this, however, we found that GABAzine had
no effect on proliferation in the presence of TTX (Fig. 3G).
We therefore turned to the idea that all of the actions
of GABAzine are solely on neurons, with GABAzine increas-
ing spiking and promoting the release of a substance that pro-
motes OPC proliferation. This would be consistent with
GABAzine having no effect in TTX (Fig. 3G), but to explain
why TTX alone has no effect (Fig. 3G) we would have to
also postulate that the spiking rate is very low in the absence
of GABAzine. If this were the case, however, the GABAA ago-
nist muscimol (which is expected to decrease the spiking rate
like TTX), should also have no effect on OPC proliferation,
but in fact it decreases proliferation and myelination (Figs.
2B and 4F).
Thus, the effects of the GABAergic agents and TTX
that we have observed apparently cannot be explained solely
in terms of an action of GABA solely on OPCs (as postulated
by Zonouzi et al., 2015) or solely on neuronal spiking. How-
ever, the combination of spiking-induced release of a factor
regulating OPC proliferation and a direct suppressive effect
of GABAA receptor activation on OPC proliferation might
explain the results. The difference in behaviour from the cere-
bellar OPCs studied by Zonouzi et al. (2015) could reflect
the difference of brain area studied.
While the exact mechanisms remain to be defined, it is
clear that the development of grey matter OPCs is locally reg-
ulated by GABA release (presumably from nearby interneur-
ons: Mangin et al., 2008), which decreases myelination but
increases internode length (Figs. 4 and 5). Consequently,
interneuron activity can tune the conduction speed of nearby
axons, and differences in the local density or activity of inter-
neurons along the path of a set of axons might lead to a spa-
tial variation (Tomassy et al., 2014) of the fraction of axons
that become myelinated, or of the internode length in the
axons that do become myelinated. A spatial variation of inter-
node length has been reported for axons in the auditory sys-
tem and is predicted to affect conduction speed (Brill et al.,
1977; Ford et al., 2015; Seidl et al., 2010).
Finally, as suggested by recent findings (Zonouzi et al.,
2015), it is likely that GABAergic effects on myelination
could play a role in pathology. Therapeutic drugs affecting
the activity of GABAA receptors might alter CNS myelination
if they are administered during the period over which oligo-
dendrocytes develop. Indeed, in rats, the anti-epileptic
GABAA agonist phenobarbital decreases myelin formation in
rat pups when administered either to the pups or to their
mothers before birth (Patsalos and Wiggins, 1982).
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